Vigabatrin in the treatment of glutaric aciduria type I.
Francois
B
B
Dr L Willems Institute, Diepenbeek, Belgium.
Jaeken
J
J
Gillis
P
P
D000592:Amino Acid Metabolism, Inborn Errors / Q000178:diet therapy / Q000188:drug therapy* / Q000378:metabolism; D000614:Aminocaproates / Q000627:therapeutic use*; D004044:Dietary Proteins / Q000008:administration & dosage; D005977:Glutarates / Q000134:cerebrospinal fluid / Q000652:urine*; D050770:Glutaryl-CoA Dehydrogenase; D006801:Humans; D007223:Infant; D008297:Male; D010088:Oxidoreductases / Q000172:deficiency; D044925:Oxidoreductases Acting on CH-CH Group Donors; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000134:cerebrospinal fluid
D000614:Aminocaproates; D004044:Dietary Proteins; D005977:Glutarates; D005680:gamma-Aminobutyric Acid; D010088:Oxidoreductases; D044925:Oxidoreductases Acting on CH-CH Group Donors; D050770:Glutaryl-CoA Dehydrogenase; D020888:Vigabatrin; C035736:glutaric acid